Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?
- 1 June 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 3 (6) , 302-314
- https://doi.org/10.1038/ncponc0511
Abstract
Nature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.Keywords
This publication has 76 references indexed in Scilit:
- Extracorporeal Photopheresis in Graft-Versus-Host Disease: Ultraviolet Radiation Mediates T Cell Senescence In VivoTransplantation, 2004
- Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsBlood, 2004
- A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host diseaseBone Marrow Transplantation, 2004
- Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?Transplant Immunology, 2003
- Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cellsLeukemia, 2003
- The North American Experience with PhotopheresisTherapeutic Apheresis, 1999
- Extracorporeal PhotochemotherapyRheumatology, 1992
- Extracorporeal photochemotherapy in the treatment of severe psoriatic arthropathyBritish Journal of Dermatology, 1992
- Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1992
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987